Management of a Red AICD Site
For a red Automated Implantable Cardioverter-Defibrillator (AICD) site, complete device removal is recommended as the definitive treatment, as this likely represents a device infection.
Initial Evaluation
- Evaluate for signs of infection including erythema, warmth, tenderness, swelling, or drainage at the generator pocket site 1
- Obtain blood cultures before starting antibiotics to identify potential bloodstream infection 1
- Avoid percutaneous aspiration of the generator pocket as part of diagnostic evaluation as this is contraindicated 1
- Consider transesophageal echocardiography (TEE) to evaluate for lead vegetations or valvular involvement if systemic symptoms are present 1
Management Algorithm
For Localized Pocket Infection:
- Complete removal of all hardware (generator and leads) is necessary even if infection appears limited to the pocket 1
- Empiric antibiotic therapy should be initiated with vancomycin to cover staphylococcal species (including MRSA) until culture results are available 1
- Switch to a more targeted antibiotic based on culture results and susceptibility testing 1
- For pocket site infection without systemic involvement:
For Systemic Infection:
- Complete device removal is still mandatory 1
- At least 2 weeks of parenteral antibiotic therapy is recommended after extraction for patients with bloodstream infection 1
- Extend to 4 weeks of parenteral therapy for patients with sustained positive blood cultures despite device removal 1
- Obtain repeat blood cultures after device removal to confirm clearance of infection 1
Reimplantation Considerations
- Delay reimplantation until blood cultures are negative for at least 72 hours 1
- The contralateral side is preferred for new device placement when required 1
- Consider temporary pacing if necessary during the treatment period 1
Common Pitfalls and Caveats
- Failure to remove the entire system (including leads) significantly increases risk of relapse 1
- Erosion of any part of the AICD implies contamination of the entire system and requires complete removal 1
- Attempting to treat with antibiotics alone without device removal is inadequate and leads to treatment failure 1
- Delaying device removal increases risk of systemic complications and mortality 1
Follow-up Care
- Monitor for resolution of infection and ensure appropriate device function if reimplantation occurs 1
- Regular device interrogation after reimplantation to ensure proper functioning 1
- Patient education regarding signs of recurrent infection and importance of follow-up 1
By following this systematic approach to management, patients with red AICD sites can be appropriately treated to minimize complications and optimize outcomes.